• 1
    Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989; 321:10141022. MEDLINE
  • 2
    Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989; 321:10921099. MEDLINE
  • 3
    Wiesner RH. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: A report of the United States FK506 Study Group. Transplantation 1998; 66:493499. MEDLINE
  • 4
    McDiarmid SV. Mycophenolate mofetil in liver transplantation. Clin Transplant 1996; 10:140145. MEDLINE
  • 5
    Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998; 338:161165. MEDLINE
  • 6
    Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997; 350:11931198. MEDLINE
  • 7
    Watson CJ, Friend PJ, Jamieson NV, Frick TW, Alexander G, Gimson AE, Calne R. Sirolimus: A potent new immunosuppressant for liver transplantation. Transplantation 1999; 67:505509. MEDLINE
  • 8
    Furukawa H, Suzuki T, Jin MB, Yamashita K, Taniguchi M, Magata S, et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: Effect of monotherapy and combined treatment with conventional drugs. Transplantation 2000; 69:235241. MEDLINE
  • 9
    Busque S, Esquivel CO, Concepcion W, So SK. Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation 1998; 65:7782. MEDLINE
  • 10
    Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation. Adv Liver Transplant 1993; 22:451473.
  • 11
    Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network—Transplant Data: 1989–1999. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 1999.
  • 12 Author unknown. One-year graft and patient survival rates by organ and year of transplant for January 1990 through December 1997, patient survival by organ and year of transplant. Accessed: August 7, 2001.
  • 13
    Van Thiel DH, Tarter R, Gavaler JS, Potanko WM, Schade RR. Liver transplantation in adults—An analysis of costs and benefits at the University of Pittsburgh. Gastroenterology 1986; 90:211216. MEDLINE
  • 14
    Office of Health Technology Assessment: Public Health Service assessment of liver transplantation, 1983. Rockville, MD, National Center for Health Services Research and Health Care Technology Assessment, 1983.
  • 15
    Lake JR, Gorman KJ, Esquivel CO, Wiesner RH, Klintmalm GB, Miller CM, et al. The impact of immunosuppressive regimens on the cost of liver transplantation—Results from the US FK506 multicenter trial. Transplantation 1995; 60:10891095. MEDLINE
  • 16
    Consumer price index. Washington, DC, Bureau of Labor Statistics, 1997.
  • 17
    Torrance GW, Siegel JE, Luce BR. Framing and design the cost-effectiveness analysis. In: GoldME, RussellLB, SiegelJE, WeinsteinMC (eds). Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:5481.
  • 18
    Brown RS, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Liver Transpl Surg 1998; 4:170176. MEDLINE
  • 19
    Health Care Financing Administration. Prospective payment system: Standardizing file. Washington, DC, Department of Health and Human Services, 1998.